Repligen Corporation Stock News

Repligen Corp (NASDAQ: RGEN ) reported Q4 FY21 sales of $186.5 million , up 72% Y/Y as reported and 73% at constant currency, with organic growth of 69%, beating the consensus of $179.29 million. The base business accounted for 64% of revenue, COVID-related sales accounted for 33% of revenue, and … Full story available on Benzinga.com

Repligen (RGEN) delivered earnings and revenue surprises of 24.62% and 3.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel In Late March Amylyx Pharma

Repligen press release (RGEN): Q4 Non-GAAP EPS of $0.81 beats by $0.16.Revenue of $186.52M (+71.7% Y/Y) beats by $8.25M.For FY2022, the company expects total revenue is expected to…

— Record revenue of $186.5 million for the quarter, and year-over-year growth of 72%

— Record revenue of $186.5 million for the quarter, and year-over-year growth of 72%

Repligen (RGEN) CEO, Tony Hunt on Q4 2021 Results - Earnings Call Transcript

Repligen (RGEN) delivered earnings and revenue surprises of 24.62% and 3.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Companies Reporting Before The Bell • Palantir Technologies (NYSE: PLTR ) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. • Organon (NYSE: OGN ) is expected to report quarterly earnings at $1.24 per share on revenue of $1.57 billion. • Perella Weinberg Partners (NASDAQ: PWP ) is likely to report quarterly earnings at $0.30 per share on revenue of $193.75 million. • Navios Maritime Partners (NYSE: NMM ) is estimated to report quarterly earnings at $4.35 per share on revenue of $272.59 million. • Portland General Electric (NYSE: POR ) is likely to report quarterly earnings at $0.76 per share on revenue of $533.13 million. • Frontline (NYSE: FRO ) is estimated to report quarterly earnings at $0.13 per share on revenue of $111.30 million. • R1 RCM (NASDAQ: RCM ) is estimated to report quarterly earnings at $0.11 per share on revenue of $399.26 million. • Fiverr International (NYSE: FVRR ) is likely to report quarterly earnings at $0.04 per share on revenue of $76.

Repligen (NASDAQ:RGEN) is scheduled to announce Q4 earnings results on Thursday, Feb. 17, before market open.The consensus EPS estimate is $0.65 (+25% Y/Y)

Let us take a look at four biotech or drug companies - RGEN, IRWD, EXEL and LGND - due to release their quarterly results on Feb 16.

Repligen (RGEN) launched three advanced affinity chromatography resins for use in gene therapy manufacturing workflows.The company said the resins — AVIPure - AAV9, AVIPure - AAV8,…

AVIPure® affinity resins address the market need for high performance and caustic stability AVIPure® affinity resins address the market need for high performance and caustic stability

Sector ETF report for PBE